No significant differences in HRQOL measured by EQ-5D-5L VAS could be detected for the variables gender, BMI, education level, relationship status, prevalence of pain/discomfort or depression/anxiety, SMA type, SMN2 copy number, scoliosis, walking ability, NIV or age at therapy onset. This evidence concerns the gene SMN2 and depressive symptom measurement.